Xperimentations.ca Bibliographie sur la

Transcription

Bibliographie sur la méthamphétamine, Xperimentations.ca
Bibliographie sur la méthamphétamine
Anglin, M.D., C. Burke, B. Perrochet, E. Stamper et S. Dawoud-Noursi. History of the
methamphetamine problem, Journal of Psychoactive Drugs, vol. 32(2), 2000, p. 137–
141.
Arendt, M., P. Munk-Jorgensen, L. Sher et S.O. Jensen. Mortality among individuals with
cannabis, cocaine, amphetamine, MDMA, and opioid use disorders: A nationwide
follow-up study of Danish substance users in treatment, Drug and Alcohol
Dependence, vol. 114(2–3), 2010, p. 134–139.
BC Mental Health and Addiction Services. Crystal meth and other amphetamines: An
integrated BC strategy, Vancouver, ministre d’État aux services en santé mentale et
en toxicomanie, 2005. Consulté sur le
www.health.gov.bc.ca/library/publications/year/2004/MHA_meth_strategy.pdf.
Barkus, E. et R.M. Murray. Substance use in adolescence and psychosis: Clarifying the
relationship [Review], Annual Review of Clinical Psychology, vol. 6, 2010, p. 365–
389.
Bartu, A., L.J. Dusci et K.F. Ilett. Transfer of methylamphetamine and amphetamine into
breast milk following recreational use of methylamphetamine, British Journal of
Clinical Pharmacology, vol. 67(4), 2009, p. 455–459.
Brunt, T.M., M. van Laar, R.J. Niesink et W. van den Brink. The relationship of quality and
price of the psychostimulants cocaine and amphetamine with health care outcomes,
Drug and Alcohol Dependence, vol. 111(1–2), 2010, p. 21–29.
Calabria, B., L. Degenhardt, C. Briegleb, T. Vos, W. Hall, M. Lynskey et coll. Systematic
review of prospective studies investigating "remission" from amphetamine, cannabis,
cocaine or opioid dependence, Addictive Behaviors, vol. 35(8), 2010, p. 741–749.
Chao, C., L.P. Jacobson, F.J. Jenkins, D. Tashkin, O. Martinez-Maza, M.D. Roth et coll.
Recreational drug use and risk of Kaposi’s sarcoma in HIV- and HHV-8-coinfected
homosexual men, AIDS Research and Human Retroviruses, vol. 25(2), 2009, p. 149–
156.
Chao, C., L.P. Jacobson, D. Tashkin, O. Martinez-Maza, M.D. Roth, J.B. Margolick et coll.
Recreational amphetamine use and risk of HIV-related non-Hodgkin lymphoma,
Cancer Causes and Control, vol. 20(5), 2009, p. 509–516.
Childs, E. et H. de Wit. Amphetamine-induced place preference in humans, Biological
Psychiatry, vol. 65(10), 2009, p. 900–904.
© Centre canadien de lutte contre l’alcoolisme et les toxicomanies | Mars 2012
Page 2 de 8
Chintalova-Dallas, R., P. Case, N. Kitsenko et Z. Lazzarini. Boltushka: A homemade
amphetamine-type stimulant and HIV risk in Odessa, Ukraine, International Journal
on Drug Policy, vol. 20(4), 2009, p. 347–351.
Christine, C.W., E.R. Garwood, L.E. Schrock, D.E. Austin et C.E. McCulloch. Parkinsonism
in patients with a history of amphetamine exposure, Movement Disorders, vol. 25(2),
2010, p. 228–231.
Colfax, G., G.M. Santos, P. Chu, E. Vittinghoff, A. Pluddemann, S. Kumar et coll.
Amphetamine-group substances and HIV, Lancet, vol. 376(9739), 2010, p. 458–474.
Daumann, J., P. Koester, B. Becker, D. Wagner, D. Imperati, E. Gouzoulis-Mayfrank et coll.
Medial prefrontal gray matter volume reductions in users of amphetamine-type
stimulants revealed by combined tract-based spatial statistics and voxel-based
morphometry, NeuroImage, vol. 54(2), 2011, p. 794–801.
Davies, A., J. Davey, A. Hunter et M. Williams. The role of amphetamine injection in
Hepatitis C and drug use risk behaviours, Brisbane (Australie), Queensland Health;
Queensland University of Technology; Brisbane Youth Service, 2002.
Dawe, S., P. Davis, K. Lapworth et R. McKetin. Mechanisms underlying aggressive and
hostile behavior in amphetamine users, Current Opinion in Psychiatry, vol. 22(3),
2009, p. 269–273.
Degenhardt, L., B. Mathers, M. Guarinieri, S. Panda, B. Phillips, S.A. Strathdee et coll.
Meth/amphetamine use and associated HIV: Implications for global policy and public
health, International Journal on Drug Policy, vol. 21(5), 2010, p. 347–358.
Degoulet, M.F., J.C. Rostain, H.N. David et J.H. Abraini. Repeated administration of
amphetamine induces a shift of the prefrontal cortex and basolateral amygdala motor
function, International Journal of Neuropsychopharmacology, vol. 12(7), 2009, p.
965–974.
Deguire, A.-É. Fiche de renseignements : La méthamphétamine, Ottawa, Centre canadien de
lutte contre l’alcoolisme et les toxicomanies, 2005. Consulté sur le
http://www.cclat.ca/2005%20CCSA%20Documents/ccsa-011135-2005.pdf.
Département Santé mentale et abus de substances psychoactives de l’OMS. Systematic
review of treatment for amphetamine-related disorders, Genève, Organisation
mondiale de la Santé, 2001.
Dietrich, J.B. Alteration of blood-brain barrier function by methamphetamine and cocaine,
Cell and Tissue Research, vol. 336(3), 2009, p. 385–392.
Page 3 de 8
Dlugos, A.M., A. Hamidovic, C.A. Hodgkinson, D. Goldman, A.A. Palmer et H. de Wit.
More aroused, less fatigued: Fatty acid amide hydrolase gene polymorphisms
influence acute response to amphetamine, Neuropsychopharmacology, vol. 35(3),
2010, p. 613–622.
Dlugos, A.M., A. Hamidovic, A.A. Palmer et H. de Wit. Further evidence of association
between amphetamine response and SLC6A2 gene variants, Psychopharmacology,
vol. 206(3), 2009, p. 501–511.
Fatovich, D.M., D.L. McCoubrie, S.J. Song, D.M. Rosen, N.D. Lawn et F.F. Daly. Brain
abnormalities detected on magnetic resonance imaging of amphetamine users
presenting to an emergency department: A pilot study, Medical Journal of Australia,
vol. 193(5), 2010, p. 266–268.
Freye, E. et J.V. Levy (éd.). Pharmacology and abuse of cocaine, amphetamines, ecstasy and
related designer drugs: A comprehensive review on their mode of action, treatment of
abuse, and intoxication, New York, Springer, 2009.
Gabbay, F.H., C.C. Duncan et C.G. McDonald. Brain potential indices of novelty processing
are associated with preference for amphetamine, Experimental and Clinical
Psychopharmacology, vol. 18(6), 2010, p. 470–488.
Gebhard, C., A. Breitenstein, A. Akhmedov, C.E. Gebhard, G.G. Camici, T.F. Luscher et
coll. Amphetamines induce tissue factor and impair tissue factor pathway inhibitor:
Role of dopamine receptor type 4, European Heart Journal, vol. 31(14), 2010, p.
1780–1791.
Goodwin, J.S., G.A. Larson, J. Swant, N. Sen, J.A. Javitch, N.R. Zahniser et coll.
Amphetamine and methamphetamine differentially affect dopamine transporters in
vitro and in vivo, Journal of Biological Chemistry, vol. 284(5), 2009, p. 2978.
Gossop, M. Review: Limited evidence to support pharmacological therapy for amphetamine
withdrawal, Evidence-based Mental Health, vol. 12(4), 2009, p. 122.
Gouzoulis-Mayfrank, E. et J. Daumann. Neurotoxicity of drugs of abuse: The case of
methylenedioxyamphetamines (MDMA, ecstasy) and amphetamines, Dialogues in
Clinical Neuroscience, vol. 11(3), 2009, p. 305–317.
Govitrapong, P., P. Boontem, P. Kooncumchoo, S. Pinweha, J. Namyen, Y. Sanvarinda et
coll. Increased blood oxidative stress in amphetamine users, Addiction Biology, vol.
15(1), 2010, p. 100–102.
Haile, C.N., T.R. Kosten et T.A. Kosten. Pharmacogenetic treatments for drug addiction:
Cocaine, amphetamine and methamphetamine, American Journal of Drug and
Alcohol Abuse, vol. 35(3), 2009, p. 161–177.
Page 4 de 8
Hakansson, A., F. Schlyter et M. Berglund. Characteristics of primary amphetamine users in
Sweden: A criminal justice population examined with the addiction severity index,
European Addiction Research, vol. 15(1), 2009, p. 10–18.
Hamidovic, A., E. Childs, M. Conrad, A. King et H. de Wit. Stress-induced changes in mood
and cortisol release predict mood effects of amphetamine, Drug and Alcohol
Dependence, vol. 109(1–3), 2010, p. 175–180.
Hantson, P. Acute neurovascular complications related to the abuse of cocaine,
amphetamines, and cannabis, Réanimation, vol. 19(6), 2010, p. 533–538.
Hatim, A.S. Amphetamine type stimulant (ATS) induced psychosis: A rising problems in
Malaysia, Malaysian Journal of Psychiatry, vol. 17(2), 2010, p. 3–6.
Helseth, V., T. Lykke-Enger, J. Johnsen et H. Waal. Substance use disorders among
psychotic patients admitted to inpatient psychiatric care, Nordic Journal of
Psychiatry, vol. 63(1), 2009, p. 72–77.
Jia, Z.W., W. Wang, C. Dye, Y.P. Bao, Z.M. Liu et L. Lu. Exploratory analysis of the
association between new-type drug use and sexual transmission of HIV in China,
American Journal of Drug and Alcohol Abuse, vol. 36(2), 2010, p. 130–133.
Konstenius, M., N. Jayaram-Lindstrom, O. Beck et J. Franck. Sustained release
methylphenidate for the treatment of ADHD in amphetamine abusers: A pilot study,
Drug and Alcohol Dependence, vol. 108(1–2), 2010, p. 130–133.
Lawyer, G., P.S. Bjerkan, A. Hammarberg, N. Jayaram-Lindstrom, J. Franck et I. Agartz.
Amphetamine dependence and co-morbid alcohol abuse: Associations to brain
cortical thickness, BMC Pharmacology, vol. 10, 2010, p. 5.
Lia, K., O. Spigset et L. Slordal. Driving under the influence of amphetamine and
metamphetamine [Kjoring under pavirkning av amfetamin og metamfetamin],
Journal of the Norwegian Medical Association, vol. 129(2), 2009, p. 105–108.
Luchansky, B., A. Krupski et K. Stark. Treatment response by primary drug of abuse: Does
methamphetamine make a difference?, Journal of Substance Abuse Treatment, vol.
32(1), 2007, p. 89–96.
Macmahon, M.J. et V.R. Tallentire. Stimulating stuff: The pathological effects of cocaine
and amphetamines on the cardiovascular system, British Journal of Diabetes and
Vascular Disease, vol. 10(5), 2010, p. 251.
Mao, L.M., W. Wang, X.P. Chu, G.C. Zhang, X.Y. Liu, Y.J. Yang et coll. Stability of surface
NMDA receptors controls synaptic and behavioral adaptations to amphetamine,
Nature Neuroscience, vol. 12(5), 2009, p. 602–610.
Page 5 de 8
Marrone, G.F., J.S. Pardo, R.M. Krauss et C.L. Hart. Amphetamine analogs
methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) differentially
affect speech, Psychopharmacology, vol. 208(2), 2010, p. 169–177.
McCloskey, M., A.A. Palmer et H. de Wit. Are attention lapses related to d-amphetamine
liking?, Psychopharmacology, vol. 208(2), 2010, p. 201–209.
McKetin, R., E. Kelly et J. McLaren. The relationship between crystalline methamphetamine
use and methamphetamine dependence, Drug and Alcohol Dependence, vol. 85,
2006, p. 198–204.
National Institute on Drug Abuse. Methamphetamine abuse and addiction (National Institute
on Drug Abuse Research Report Series), National Institute of Health Publication #064210, 2006.
Oei, J., M.E. Abdel-Latif, R. Clark, F. Craig et K. Lui. Short-term outcomes of mothers and
infants exposed to antenatal amphetamines, Archives of Disease in Childhood: Fetal
and Neonatal Edition, vol. 95(1), 2010, p. F36–F41.
Pates, R. et D. Riley (éd.). Interventions for amphetamine misuse, Wiley-Blackwell, 2009.
Pilgrim, J.L., D. Gerostamoulos, O.H. Drummer et M. Bollmann. Involvement of
amphetamines in sudden and unexpected death, Journal of Forensic Sciences, vol.
54(2), 2009, p. 478–485.
Reske, M., C.A. Eidt, D.C. Delis et M.P. Paulus. Nondependent stimulant users of cocaine
and prescription amphetamines show verbal learning and memory deficits, Biological
Psychiatry, vol. 68(8), 2010, p. 762–769.
Schifano, F., J. Corkery, V. Naidoo, A. Oyefeso et H. Ghodse. Overview of amphetaminetype stimulant mortality data: UK, 1997–2007, Neuropsychobiology, vol. 61(3), 2010,
p. 122–130.
Seger, D. Cocaine, metamfetamine, and MDMA abuse: The role and clinical importance of
neuroadaptation, Clinical Toxicology (Philadelphia, Pa.), vol. 48(7), 2010, p. 695–
708.
Sevak, R.J., W.W. Stoops, L.R. Hays et C.R. Rush. Discriminative stimulus and subject-rated
effects of methamphetamine, d-amphetamine, methylphenidate, and triazolam in
methamphetamine-trained humans, Journal of Pharmacology and Experimental
Therapeutics, vol. 328(3), 2009, p. 1007–1018.
Shoptaw, S.J., U. Kao, K. Heinzerling et W. Ling. Treatment for amphetamine withdrawal,
Base de données d’examens systématiques de Cochrane (en ligne), vol. 2(2),
CD003021, 2009.
Page 6 de 8
Shoptaw, S.J., U. Kao et W. Ling. Treatment for amphetamine psychosis, Base de données
d’examens systématiques de Cochrane (en ligne), vol. 1(1), CD003026, 2009.
Singleton, J., L. Degenhardt, W. Hall et T. Zabransky. Mortality among amphetamine users:
A systematic review of cohort studies, Drug and Alcohol Dependence, vol. 105(1–2),
2009, p. 1–8.
Sommers, I., D. Baskin et A. Baskin-Sommers. Methamphetamine use among young adults:
Health and social consequences, Addictive Behaviours, vol. 31, 2006, p. 1469–1476.
Stanley, M.D., M.M. Poole, W.W. Stoops et C.R. Rush. Amphetamine self-administration in
light and moderate drinkers, Alcoholism, Clinical and Experimental Research, vol.
35(3), 2010, p. 443–453.
Vocci, F.J. et I.D. Montoya. Psychological treatments for stimulant misuse, comparing and
contrasting those for amphetamine dependence and those for cocaine dependence,
Current Opinion in Psychiatry, vol. 22(3), 2009, p. 263–268.
Wan Raihana, W.A., S.H. Gan et S.C. Tan. Stereoselective method development and
validation for determination of concentrations of amphetamine-type stimulants and
metabolites in human urine using a simultaneous extraction-chiral derivatization
approach, Journal of Chromatography B: Analytical Technologies in the Biomedical
and Life Sciences, vol. 879(1), 2010, p. 8–16.
Wan, J. et S. Hong. Research advancement on relationship between dependence of
amphetamine-type stimulants and central nervous cholinergic system, Progress in
Modern Biomedicine, vol. 9(23), 2009, p. 4593–4597.
Westover, A.N. et P.A. Nakonezny. Aortic dissection in young adults who abuse
amphetamines, American Heart Journal, vol. 160(2), 2010, p. 315–321.
Wiig, K.A., J.R. Whitlock, M.H. Epstein, R.L. Carpenter et M.F. Bear. The levo enantiomer
of amphetamine increases memory consolidation and gene expression in the
hippocampus without producing locomotor stimulation, Neurobiology of Learning
and Memory, vol. 92(1), 2009, p. 106–113.
Wu, L., W.E. Schlenger et D.N. Galvin. Concurrent use of methamphetamine, MDMA, LSD,
ketamine, GHB, and flunitrazepam among American youths, Drug and Alcohol
Dependence, vol. 84(1), 2006, p. 102–113.
Wu, L.T., D.G. Blazer, A.A. Patkar, M.L. Stitzer, P.G. Wakim et R.K. Brooner.
Heterogeneity of stimulant dependence: A national drug abuse treatment clinical trials
network study, American Journal on Addictions, vol. 18(3), 2009, p. 206–218.
Page 7 de 8
Zorick, T.S., D. Rad, C. Rim et J. Tsuang. An overview of methamphetamine induced
psychotic syndromes, Addictive Disorders and Their Treatment, vol. 7(3), 2008, p.
143–156.
Centre canadien de lutte contre l’alcoolisme et les toxicomanies
75, rue Albert, bureau 500 | Ottawa (Ontario) K1P 5E7 | Canada
Tél. : 613-235-4048 | Téléc. : 613-235-8101 | [email protected]
Page 8 de 8

Xperimentations.ca Bibliographie sur la

Transcription

Documents pareils

Xperimentations.ca Bibliographie sur la psilocybine

European Athletics Result Service

Xperimentations.ca Bibliographie sur la